Home 5 Articles 5 Agency Draws a New Line on SARS-CoV-2 Antibody Serology Tests

Agency Draws a New Line on SARS-CoV-2 Antibody Serology Tests

by | Jun 8, 2020

It took a while but the FDA has finally come to the realization that letting blood-based serology tests for detection of SARS-CoV-2 antibody tests into the U.S. market without requiring test makers to prove the value of their products was a bad idea. And now the agency is walking back the policy, at least in […]

It took a while but the FDA has finally come to the realization that letting blood-based serology tests for detection of SARS-CoV-2 antibody tests into the U.S. market without requiring test makers to prove the value of their products was a bad idea. And now the agency is walking back the policy, at least in […]

This content is Exclusive to Lab Industry Report Subscribers

Subscribe or Log in for Exclusive Access.